(Q40625910)

22 September 2017

Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia (English)

1 reference

22 September 2017

Klebsiella pneumoniae

0 references

author name string

Ariffin H

1

1 reference

22 September 2017

Navaratnam P

2

1 reference

22 September 2017

Mohamed M

3

1 reference

22 September 2017

Arasu A

4

1 reference

22 September 2017

Abdullah WA

5

1 reference

22 September 2017

Lee CL

6

1 reference

22 September 2017

Peng LH

7

1 reference

22 September 2017

1 January 2000

1 reference

International Journal of Infectious Diseases

22 September 2017

1 reference

22 September 2017

4

1 reference

22 September 2017

1

1 reference

22 September 2017

21-25

1 reference

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

More extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Synergy between clavulanic acid and newer β-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmnella typhimurium resistant to third-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2800%2990061-4

7 January 2021

10.1016/S1201-9712(00)90061-4

Identifiers

DOI

1 reference

22 September 2017

1 reference